Potential for independent research in brain cancer.

Qualifications of the investigative team to perform the proposed research.

A second year of funding may be requested if substantial progress has been demonstrated.

Semi-annual and end-of-project reports are required. Applications will not be funded until approval is obtained from the committees overseeing animals, radiation, human subjects, and hazardous materials. Principal investigator salaries or purchase of equipment are not allowable. These sub-awards of up to $50,000 are inclusive of your institutional F&A costs.įunds can be used for technical support or supplies.

Awards to investigators affiliated with other institutions will be issued as sub-awards.

Awards to investigators affiliated with UCLA will provide direct costs plus institutional F&A costs.

One-year awards of up to $50,000 (direct costs) will be given as of August 1, 2021. The program encourages high risk/high impact projects that take advantage of new research opportunities in the brain cancer research field and promote multidisciplinary collaboration between basic, preclinical and clinical programs.ĭRP Awards are available for faculty members associated with UCLA, as well as institutions within the surrounding community, to support innovative translational research in all areas of investigation that impact brain cancer.

The DRP supports pilot projects focusing on innovative and interdisciplinary translational research. The SPORE program was initiated by the National Cancer Institute to promote interactions between basic and applied investigators as well as to provide them with the flexibility to rapidly evaluate new approaches for the prevention, early detection, diagnosis, and treatment of human cancer.Įach SPORE allocates effort to two distinct funding programs, the Developmental Research Program (DRP) and the Career Enhancement Program (CEP). Image from Shivani Sharma’s CEP proposal 'Nanoscale analysis of glioblastoma extracellular vesicles.' Extracellular vesicles were observed to have nanofilaments in GBM U87 cells but not in control normal human astrocyte (NHA), as imaged by atomic force microscopy (AFM).

Address map for spore app